The Revival of Big Pharma in Mental Health: What's Behind the Resurgence
2025-03-14
The Wall Street Journal
The mental health industry was once a lucrative market for pharmaceutical companies, with blockbuster drugs like Prozac generating billions of dollars in revenue. However, in recent years, many big pharma companies walked away from mental health research. Now, with advancements in neuroscience and the development of innovative treatments, some companies are revisiting the field, driven by the growing demand for effective mental health solutions and the potential for significant returns on investment in areas like depression treatment and anxiety disorders.
